Search for: "Eli Lilly & Co."
Results 601 - 620
of 1,009
Sort by Relevance
|
Sort by Date
1 Nov 2010, 1:00 pm
Eli Lilly and Co., No. 2010-1105, (Nov. 1, 2010, Order)Eli Lilly filed a first application describing a new class of chemical compounds having antiviral utility, including the compound named gemcitabine. [read post]
27 Oct 2010, 8:30 am
In order to satisfy the best mode requirement, the inventor must disclose the preferred embodiment of his invention as well as any preferences that could materially affect the invention.[2] The first step in a best mode inquiry begins, as is always the case with patent law, with the claims.[3] This past March the Federal Circuit handed down a decision in Ajinomoto Co. v. [read post]
27 Oct 2010, 3:38 am
General GSK forms alliance for development of gene therapy techniques for rare diseases (Patent Docs) Emerging economies’ new initiative on falsified and substandard medicines (IP Watch) Michèle Rivasi asks question about ACTA and Access to Medicine (KEI) As negotiators launch talks on biodiversity, industry requests IP protection (IP Watch) Negotiators persist on biodiversity benefit-sharing treaty despite slipping deadlines (IP Watch) New draft biodiversity treaty text shows much work… [read post]
25 Oct 2010, 4:30 am
Eli Lilly & Co., No. 09-5004-CV, 2010 WL 3853003 (2d Cir. [read post]
22 Oct 2010, 9:30 am
Eli Lily and Co., CCH RICO Business Disputes Guide ¶11,936.Further information about CCH RICO Business Disputes Guide appears here. [read post]
19 Oct 2010, 12:20 pm
Eli Lilly & Co., 2010 WL 4024922 (D.S.D. [read post]
19 Oct 2010, 9:09 am
One company, Eli Lilly, was responsible for a large amount of the Harvard payments, including 50 percent in 2009 and 33 percent in the first three months of 2010. [read post]
12 Oct 2010, 8:56 pm
Apotex asks Supreme Court to review generic Cozaar/Hyzaar 180-day exclusivity decision (FDA Law Blog) Faslodex (Fulvestrant) – US: AstraZeneca seeks review of BPAI decision concerning patent covering ‘Use of Fulvestrant in treatment of resistant breast cancer’ (Patent Docs) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against Dr Reddy’s following Para IV certification (Patent Docs) Lipitor (Atorvastatin) – US: Generic… [read post]
11 Oct 2010, 5:56 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
10 Oct 2010, 6:21 am
Also brought within the IPO’s corral is the decision in Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Co Ltd [2010] RPC 8 (noted by the IPKat here), in which the Court of Appeal delved into the murky depths of selection invention – asking, in the process, where a wise man would hide a leaf… The sections on supplementary protection certificates has also been updated in light of the decisions of the High Court in Yeda Research and Development… [read post]
6 Oct 2010, 7:46 am
Eli Lilly and Co., 2010 WL 3892464, at *1 (S.D. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
3 Oct 2010, 8:57 pm
Eli Lilly & Co. 1:10-cv-06275; filed September 30, 2010 in the Northern District of Illinois Declaratory judgment of non-infringement of U.S. [read post]
28 Sep 2010, 3:14 pm
Eli Lilly & Co. [read post]
27 Sep 2010, 12:32 pm
Eli Lilly and Co., manufacturer of Thimerosal, began tests on the product back in the 1930s and some say the company suppressed important information on the toxicity of thimerosal until now. [read post]
27 Sep 2010, 12:32 pm
Eli Lilly and Co., manufacturer of Thimerosal, began tests on the product back in the 1930s and some say the company suppressed important information on the toxicity of thimerosal until now. [read post]
23 Sep 2010, 9:37 pm
Noonan -- The Washington Legal Foundation (WLF), a self-styled "non-profit public interest law and policy center that regularly appears before federal and state courts to promote economic liberty, free enterprise, and a limited and accountable government," filed an amicus curiae brief on September 8th, urging the Federal Circuit to rehear en banc Eli Lilly's appeal of the Court's affirmance of an invalidity finding of U.S. [read post]
17 Sep 2010, 7:33 am
Eli Lilly and Company, __ F.3d __, 2010 WL 3516183 (2d Cir. [read post]
16 Sep 2010, 4:43 pm
Eli Lilly & Co., No. 09-0222-cv, Slip op. [read post]
16 Sep 2010, 4:58 am
Eli Lilly & Co., No. 09-0222 (2d Cir. 9/10/10). [read post]
